Related Experiment Video
Updated: Jun 18, 2025

06:36
Lower Limb Biomechanical Analysis of Healthy Participants
Published on: April 15, 2020
9.0K
A Novel Method for Identifying Frailty and Quantifying Muscle Strength Using the Six-Minute Walking Test
Yunjin Zhang1, Minoru Morita1, Tsunahiko Hirano2
1Faculty of Engineering, Graduate School of Sciences and Technology for Innovation, Yamaguchi University, 2-16-1 Tokiwadai, Ube 755-8611, Japan.
Sensors (Basel, Switzerland)
|July 27, 2024
Summary
This study introduces a wearable system for the six-minute walking test (6MWT) to detect frailty and sarcopenia in the elderly. The system quantifies walking muscle strength (WMS) and identifies frail individuals using stride length and step cadence analysis.
Area of Science:
- Gerontology
- Biomedical Engineering
- Physical Therapy
Background:
- Frailty and sarcopenia accelerate cardiovascular aging in the elderly.
- Early detection of frailty and sarcopenia is critical for effective treatment planning.
- The six-minute walking test (6MWT) is a key measure of exercise tolerance in cardiorespiratory conditions.
Purpose of the Study:
- To develop a wearable system for conducting the 6MWT.
- To propose a novel method for identifying frailty and quantifying walking muscle strength (WMS).
- To analyze gait parameters like stride length (SL) and step cadence (SC) for assessing walking performance.
Main Methods:
- 60 elderly participants wore ankle accelerometers during the 6MWT.
- Gait data (SL and SC) were collected via computer or smartphone.
- A classification system using SL and SC ranges (I-IV) was implemented to assess frailty.
- A quantitative Walking Muscle Strength (WMS) score was developed.
Main Results:
- Frail individuals were predominantly found in Range III (62.5%), while non-frail individuals were in Range I (72.4%).
- 62.5% of frail participants received a low WMS score (WMS1), contrasted with 41.4% of non-frail individuals scoring higher (WMS4).
- Average walking distances decreased with lower WMS scores, ranging from 207 m (WMS1) to 462 m (WMS4).
Conclusions:
- The wearable 6MWT system effectively analyzes gait parameters for frailty assessment.
- The proposed WMS score offers a quantitative method for evaluating sarcopenia or frailty.
- This technology aids in early detection and management of age-related muscle weakness and reduced cardiopulmonary function.

